Cancer Family
Connective and Soft Tissue Neoplasm
CI-CAN-00000010Explore in graph →
Non-malignant849 active trials17 approved drugs339 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000010Explore in graph →
Clinical trials
3,878 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03611868 | A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors | active not recruiting | Phase 1 / Phase 2 | 230 | Ascentage Pharma Group Inc.INDUSTRY | 2 | Aug 7, 2025 | clinicaltrials |
| NCT05862272 | A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis | recruiting | Phase 3 | 1,000 | Sumitomo Pharma Switzerland GmbHINDUSTRY | 1 | Aug 6, 2025 |
| clinicaltrials |
| NCT05947149 | HRQoL in Patients With Solid Tumors Treated With Hadrontherapy(HadroQoL) | recruiting | — | 180 | CNAO National Center of Oncological HadrontherapyOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT07106411 | CEH-EUS for Differentiating GISTs and Leiomyomas: A Multicenter Prospective Self-Controlled Study | not yet recruiting | — | 288 | Huazhong University of Science and TechnologyOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT06541652 | A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers(FFCD-2205) | recruiting | — | 150 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Aug 5, 2025 | clinicaltrials |
| NCT07104955 | Salutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and Safety | recruiting | N/A | 40 | Salutare Group Ltd.INDUSTRY | 1 | Aug 5, 2025 | clinicaltrials |
| NCT06522165 | Pediatric Oncological Orthopaedic Reconstruction | active not recruiting | — | 400 | Costantino ErraniOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT06772233 | A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment | not yet recruiting | Phase 2 | 100 | Peking UniversityOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT07078136 | Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis | recruiting | — | 130 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT06214767 | Study on Treatment Decision-Making and Prognostic Follow-Up for Untreated Cerebral Cavernous Malformations | recruiting | — | 1,200 | Beijing Tiantan HospitalOTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT06277154 | MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma | recruiting | Phase 2 | 148 | HRYZ Biotech Co.INDUSTRY | 1 | Jul 24, 2025 | clinicaltrials |
| NCT07074795 | Use of Nitrous Oxide During Office Hysteroscopy | active not recruiting | N/A | 400 | Maaynei Hayesha Medical CenterOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT06367075 | A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma | recruiting | Phase 2 | 53 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT07072143 | An International Study on Pediatric Patients With Rare Tumors.(PARTNER) | recruiting | — | 6,250 | Azienda Ospedaliera di PadovaOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT05679921 | Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue Sarcoma | recruiting | Phase 2 | 116 | Yonsei UniversityOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT07067255 | Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer(BAH2573-104) | recruiting | Phase 1 / Phase 2 | 80 | Essen BiotechOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT07066982 | Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas(BAH2573-103) | recruiting | Phase 1 / Phase 2 | 60 | Essen BiotechOTHER | 1 | Jul 15, 2025 | clinicaltrials |
| NCT04658771 | MR-HIFU Treatment of Painful Osteoid Osteoma | active not recruiting | Phase 2 | 30 | Children's National Research InstituteOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT06751251 | The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination | active not recruiting | — | 200 | Peking University People's HospitalOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT06632860 | A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors | recruiting | Early Phase 1 | 40 | Peking Union Medical College HospitalOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT07048184 | Sarcoma Surgery Wound Complications Comparing Usual Versus Negative Pressure Dressing(SUNDIAL) | not yet recruiting | Phase 2 | 94 | NHS Greater Glasgow and ClydeOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT07056023 | Multicenter Trial on Surgical Outcome and Quality of Life in Juxta-medullary Tumors(EURJMT) | recruiting | — | 100 | University Hospital MuensterOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT04986748 | Using QPOP to Predict Treatment for Sarcomas and Melanomas | recruiting | — | 100 | National Cancer Centre, SingaporeOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT07044076 | Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With Meningiomas(MenQOL) | recruiting | — | 50 | Centre Hospitalier St AnneOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT07039968 | Standard Dose Versus High Dose Stereotactic Spine Radiosurgery for Metastatic Spinal Neoplasms | recruiting | Phase 2 | 196 | National Taiwan University HospitalOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT04617327 | Pre-operative RadiothErapy for Soft Tissue SarcOmas(PRESTO) | active not recruiting | N/A | 15 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT06114004 | Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma (SeliSarc)(SeliSarc) | recruiting | Phase 2 | 88 | Asociación Europea y Latinoamericana SELNET para la Investigación en SarcomasOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT06036706 | Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma:(CANCER-COG) | recruiting | N/A | 108 | Centre Francois BaclesseOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT06875700 | Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients | recruiting | — | 300 | University of UtahOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT07014163 | Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) Injection in the Management of Superficial Lipomas | recruiting | N/A | 10 | Espad PharmedINDUSTRY | 1 | Jun 10, 2025 | clinicaltrials |
| NCT00470223 | Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma(OS2006) | active not recruiting | Phase 3 | 318 | UNICANCEROTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT05944237 | HTL0039732 in Participants With Advanced Solid Tumours | recruiting | Phase 1 / Phase 2 | 150 | Cancer Research UKOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT05427461 | Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2(SAMHY2) | active not recruiting | N/A | 20 | Institut Claudius RegaudOTHER | 1 | Jun 3, 2025 | clinicaltrials |
| NCT05115331 | Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease(1-2 PUNCH) | active not recruiting | Phase 3 | 168 | University of CincinnatiOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT06827717 | Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma | recruiting | Phase 2 | 29 | Sun Yat-sen UniversityOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT05357768 | Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) Project(GRACefUl) | recruiting | — | 260 | Istituto Ortopedico RizzoliOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT01793168 | Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford(CoRDS) | recruiting | — | 20,000 | Sanford HealthOTHER | 2 | May 29, 2025 | clinicaltrials |
| NCT06991595 | Fertility Limiting Diseases of Pelvic Organs and Their Influence on Receptivity of Endometrial Cavity: Prospective Clinical Trial(REAdME) | recruiting | — | 236 | Charles University, Czech RepublicOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT05999396 | FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer(CoRe_CC-3) | recruiting | Phase 1 | 89 | German Cancer Research CenterOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT06979115 | Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors(ICG-BST) | not yet recruiting | — | 40 | Guangdong Provincial People's HospitalOTHER | 1 | May 18, 2025 | clinicaltrials |
| NCT05477680 | Intraoperative Brain Shift Calculation Study(BRASH) | recruiting | N/A | 100 | Sklifosovsky Institute of Emergency CareOTHER_GOV | 1 | May 16, 2025 | clinicaltrials |
| NCT05484245 | Sonography-guided Resection of Brain Mass Lesions(SOMALI) | recruiting | N/A | 100 | Sklifosovsky Institute of Emergency CareOTHER_GOV | 1 | May 16, 2025 | clinicaltrials |
| NCT04072042 | BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma(BIOVAS) | recruiting | Phase 2 | 30 | Ruijin HospitalOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT06165419 | Definitive Radiation for High-Risk Spine Metastases | recruiting | Phase 2 | 26 | Stony Brook UniversityOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT05062707 | Early Ageing During Therapy in AYA Cancer Patients | recruiting | — | 120 | University Medical Center GroningenOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT05894018 | Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma(RAFAS-001) | recruiting | Phase 2 | 32 | Fujun ZhangOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06332274 | tislelizUMaB in canceR Patients With molEcuLar residuaL Disease(UMBRELLA) | recruiting | Phase 3 | 717 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT05386615 | Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids | recruiting | — | 200 | InSightecINDUSTRY | 2 | Apr 30, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Aug 7, 2025source: clinicaltrials